Thomas L. Hearn

611 total citations
22 papers, 495 citations indexed

About

Thomas L. Hearn is a scholar working on Immunology, Infectious Diseases and Physiology. According to data from OpenAlex, Thomas L. Hearn has authored 22 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Infectious Diseases and 4 papers in Physiology. Recurrent topics in Thomas L. Hearn's work include Clinical Laboratory Practices and Quality Control (4 papers), T-cell and Retrovirus Studies (3 papers) and HIV Research and Treatment (3 papers). Thomas L. Hearn is often cited by papers focused on Clinical Laboratory Practices and Quality Control (4 papers), T-cell and Retrovirus Studies (3 papers) and HIV Research and Treatment (3 papers). Thomas L. Hearn collaborates with scholars based in United States and Uganda. Thomas L. Hearn's co-authors include James A. Hearn, Demetrios S. Sgoutas, S.A. Lewis, Janet K.A. Nicholson, J. Steven McDougal, Annegret Gerber, John Hancock, Austin Demby, Robert L. Hunter and Robert K. Martin and has published in prestigious journals such as American Journal of Public Health, Annals of the New York Academy of Sciences and Journal of Clinical Microbiology.

In The Last Decade

Thomas L. Hearn

22 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas L. Hearn United States	11	94	94	90	82	75	22	495
Courtney Mills United States	7	16 0.2×	408 4.3×	115 1.3×	28 0.3×	20 0.3×	8	599
Fatemeh Farshadpour Iran	17	60 0.6×	376 4.0×	184 2.0×	74 0.9×	7 0.1×	48	810
Sandra Pampuro Argentina	11	65 0.7×	46 0.5×	180 2.0×	35 0.4×	190 2.5×	19	395
Jong Hyeon Seok South Korea	11	10 0.1×	129 1.4×	102 1.1×	57 0.7×	3 0.0×	22	388
Milene Dias Miranda Brazil	16	11 0.1×	126 1.3×	333 3.7×	112 1.4×	23 0.3×	49	827
Huijie Chen China	12	98 1.0×	112 1.2×	47 0.5×	58 0.7×	1 0.0×	32	474
Aaron M. Teitelbaum United States	11	8 0.1×	65 0.7×	113 1.3×	28 0.3×	70 0.9×	24	385
Nai-Wan Hsiao Taiwan	9	10 0.1×	214 2.3×	88 1.0×	94 1.1×	13 0.2×	10	571
Benford Mafuvadze United States	16	7 0.1×	76 0.8×	88 1.0×	38 0.5×	2 0.0×	24	655

Countries citing papers authored by Thomas L. Hearn

Since Specialization

Citations

This map shows the geographic impact of Thomas L. Hearn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas L. Hearn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas L. Hearn more than expected).

Fields of papers citing papers by Thomas L. Hearn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas L. Hearn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas L. Hearn. The network helps show where Thomas L. Hearn may publish in the future.

Co-authorship network of co-authors of Thomas L. Hearn

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas L. Hearn. A scholar is included among the top collaborators of Thomas L. Hearn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas L. Hearn. Thomas L. Hearn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Robert K., Thomas L. Hearn, John C. Ridderhof, & Austin Demby. (2005). Implementation of a quality systems approach for laboratory practice in resource-constrained countries. AIDS. 19(Supplement 2). S59–S65. 26 indexed citations

Inhorn, Stanley L., John Hancock, Barbara Keller, et al.. (2004). Comparison of Cytology Proficiency Testing. Acta Cytologica. 48(6). 788–794. 50 indexed citations

Williams, Laurina O., Sharon Blumer, W O Schalla, et al.. (2000). Laboratory performance in HTLV‐I/II analysis. Transfusion. 40(12). 1514–1521. 6 indexed citations

Keenlyside, Richard A., John Hancock, Richard D. Cohn, et al.. (1999). Do Proficiency Test Results Correlate With the Work Performance of Screeners Who Screen Papanicolaou Smears?. American Journal of Clinical Pathology. 112(6). 769–776. 25 indexed citations

Astles, J. Rex, et al.. (1998). Impact of quality control on accuracy in enzyme immunoassay testing for human immunodeficiency virus type 1 antibodies.. PubMed. 122(8). 700–7. 2 indexed citations

Schalla, W O, et al.. (1998). Assessment of the impact of a CD4+ T-cell testing laboratory improvement program.. PubMed. 122(6). 512–9. 1 indexed citations

Tomasi, M., Mark T. Dertzbaugh, Thomas L. Hearn, Robert L. Hunter, & Charles O. Elson. (1997). Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization. European Journal of Immunology. 27(10). 2720–2725. 18 indexed citations

Hearn, Thomas L., et al.. (1996). Multiple Emulsions Oral Vaccine Vehicles for Inducing Immunity or Tolerance. Annals of the New York Academy of Sciences. 778(1). 388–389. 9 indexed citations

Nicholson, Janet K.A., et al.. (1994). 1994 revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infections. 43. 89 indexed citations

10.

Schalla, W O, et al.. (1990). CDC's Model Performance Evaluation Program: assessment of the quality of laboratory performance for HIV-1 antibody testing.. PubMed. 105(2). 167–71. 19 indexed citations

11.

Benenson, Abram S., et al.. (1990). Reporting the results of human immunodeficiency virus testing.. PubMed. 262(24). 3435–8. 14 indexed citations

12.

Hearn, Thomas L., et al.. (1987). Polyunsaturated Fatty Acids and Fat in Fish Flesh for Selecting Species for Health Benefits. Journal of Food Science. 52(5). 1209–1211. 101 indexed citations

13.

Hearn, Thomas L., et al.. (1987). Stability of Polyunsaturated Fatty Acids after Microwave Cooking of Fish. Journal of Food Science. 52(5). 1430–1431. 26 indexed citations

14.

Spierto, F W, Thomas L. Hearn, Frank H. Gardner, & W. Harry Hannon. (1985). Phenylalanine analyses of blood-spot control materials: preparation of samples and evaluation of interlaboratory performance.. Clinical Chemistry. 31(2). 235–238. 6 indexed citations

15.

Duncan, P H, et al.. (1984). Results of a nationwide survey of analyses for creatine kinase and creatine kinase isoenzymes.. Clinical Chemistry. 30(1). 33–37. 4 indexed citations

16.

Hearn, Thomas L., et al.. (1982). Laboratory evaluation and assistance efforts: mailed, on-site and blind proficiency testing surveys conducted by the Centers for Disease Control.. American Journal of Public Health. 72(12). 1364–1368. 23 indexed citations

17.

Hearn, Thomas L. & W. Harry Hannon. (1982). Interlaboratory surveys of the quantitation of thyroxin and thyrotropin (thyroid-stimulating hormone) in dried blood spot specimens.. Clinical Chemistry. 28(10). 2022–2025. 6 indexed citations

18.

Hearn, Thomas L., et al.. (1979). Comparison of interlaboratory results for blood lead with results from a definitive method.. Clinical Chemistry. 25(3). 389–393. 47 indexed citations

19.

Rees, E. Douglas, et al.. (1976). Halofenate in the treatment of type II hyperlipoproteinemia Double blind comparison with clofibrate. Atherosclerosis. 24(3). 537–549. 1 indexed citations

20.

Smith, Walter T. & Thomas L. Hearn. (1972). Substituent effects in 2-pyridone-catalyzed mutarotation. Bioorganic Chemistry. 2(1). 39–43. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact